title: PALB2 mutations and breast-cancer risk.
authors.affiliation: From the Health Disparities Research Section, Laboratory of Epidemiology and Populations Sciences, National Institute on Aging, National Institutes of Health, Baltimore (M.K.E.).
authors.forename: Michele K
authors.initials: MK
authors.lastname: Evans
authors.forename: Dan L
authors.initials: DL
authors.lastname: Longo
mesh_terms: D001943:Breast Neoplasms / Q000151:congenital* / Q000235:genetics; D000076164:Fanconi Anemia Complementation Group N Protein; D005260:Female; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease; D018095:Germ-Line Mutation; D006801:Humans; D009687:Nuclear Proteins / Q000235:genetics*; D025521:Tumor Suppressor Proteins / Q000235:genetics*
chemical_list: D000076164:Fanconi Anemia Complementation Group N Protein; D009687:Nuclear Proteins; C512790:PALB2 protein, human; D025521:Tumor Suppressor Proteins
references.citation: Transl Res. 2012 Sep;160(3):178-97
references.pmid: 22683426
references.citation: Nature. 2005 Apr 14;434(7035):917-21
references.pmid: 15829967
references.citation: N Engl J Med. 2014 Aug 7;371(6):497-506
references.pmid: 25099575
references.citation: Cancer Res. 2010 Oct 1;70(19):7353-9
references.pmid: 20858716
references.citation: Cancer. 2012 Mar 1;118(5):1362-70
references.pmid: 21932393
references.citation: Cancer Res. 2006 Aug 15;66(16):8109-15
references.pmid: 16912188
references.citation: Cancer Res. 2011 Mar 15;71(6):2222-9
references.pmid: 21285249
references.citation: Breast Cancer Res Treat. 2011 Feb;126(1):227-30
references.pmid: 21113654
references.citation: Nat Rev Cancer. 2011 Dec 23;12(1):68-78
references.pmid: 22193408